EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,952,385 | +8.6% | 89,354 | -5.0% | 0.03% | +28.6% |
| Q2 2023 | $1,797,372 | -2.5% | 94,054 | -0.9% | 0.02% | -8.7% |
| Q1 2023 | $1,843,057 | +21.0% | 94,954 | 0.0% | 0.02% | +15.0% |
| Q4 2022 | $1,523,062 | +3.8% | 94,954 | +1.4% | 0.02% | -4.8% |
| Q3 2022 | $1,468,000 | -24.5% | 93,607 | +0.2% | 0.02% | -27.6% |
| Q2 2022 | $1,945,000 | -15.4% | 93,407 | -7.9% | 0.03% | +20.8% |
| Q1 2022 | $2,299,000 | +22.7% | 101,391 | -1.0% | 0.02% | +14.3% |
| Q4 2021 | $1,873,000 | -16.1% | 102,449 | -3.0% | 0.02% | -19.2% |
| Q3 2021 | $2,233,000 | +15.2% | 105,649 | -0.7% | 0.03% | +18.2% |
| Q2 2021 | $1,938,000 | -16.5% | 106,388 | +3.5% | 0.02% | -21.4% |
| Q1 2021 | $2,321,000 | +13.2% | 102,761 | +0.5% | 0.03% | +3.7% |
| Q4 2020 | $2,051,000 | -19.4% | 102,211 | -1.9% | 0.03% | -28.9% |
| Q3 2020 | $2,546,000 | -5.5% | 104,144 | -8.2% | 0.04% | -5.0% |
| Q2 2020 | $2,694,000 | +37.5% | 113,478 | -0.3% | 0.04% | +17.6% |
| Q1 2020 | $1,959,000 | -3.9% | 113,764 | -1.7% | 0.03% | +21.4% |
| Q4 2019 | $2,039,000 | -7.4% | 115,743 | -7.1% | 0.03% | -3.4% |
| Q3 2019 | $2,202,000 | -15.3% | 124,525 | +2.4% | 0.03% | -17.1% |
| Q2 2019 | $2,599,000 | -8.3% | 121,602 | +2.1% | 0.04% | -12.5% |
| Q1 2019 | $2,835,000 | +22.2% | 119,117 | +1.0% | 0.04% | +8.1% |
| Q4 2018 | $2,320,000 | +17.3% | 117,943 | +5.7% | 0.04% | +37.0% |
| Q3 2018 | $1,977,000 | – | 111,592 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |